Undervalued Stocks Based On Cash Flows

Ergebnisse

32

4 neu

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

32 Unternehmen

UnternehmenLetzter Preis7D Rückkehr1J RückkehrMarktkapitalisierungAnalysten ZielBewertungWachstumDiv. RenditeIndustrie
6185
HK$23.00-0.8%-53.9%HK$9.7bHK$50.454.457.2%0%Pharmaceuticals & Biotech
3696
HK$40.98-2.6%n/aHK$23.5bHK$80.6553.2116.2%n/aPharmaceuticals & Biotech
1651
Neu
HK$56.9519.8%142.5%HK$21.0bHK$66.0516.515.7%3.2%Capital Goods
1318
HK$53.70-12.4%-47.8%HK$26.3bHK$98.5318.817.1%2.2%Household
6990
Neu
HK$508.005.6%27.1%HK$121.4bHK$567.1150.845.3%n/aPharmaceuticals & Biotech
1364
HK$23.160.3%-5.1%HK$55.1bHK$30.8515.213.3%2.2%Consumer Services
9926
HK$96.053.1%-39.0%HK$88.5bHK$168.9824.945.1%n/aPharmaceuticals & Biotech
2259
HK$131.4011.2%n/aHK$351.7bHK$192.6020.018.3%1.1%Materials
1801
Neu
HK$90.953.2%-0.5%HK$158.3bHK$118.15167.532.6%n/aPharmaceuticals & Biotech
697
HK$1.816.2%-7.4%HK$14.7bHK$2.6647.237.3%2.1%Real Estate Management and Development
2252
HK$22.0010.0%0.2%HK$22.7bHK$36.0735.490.9%n/aHealthcare
1866
HK$9.292.7%43.7%HK$13.5bHK$12.9312.425.4%4.0%Materials
2315
HK$55.5515.3%126.0%HK$50.9bHK$62.0373.541.0%n/aPharmaceuticals & Biotech
2235
HK$7.000.7%1.4%HK$2.9bHK$11.8362.345.0%n/aHealthcare
2145
HK$28.04-5.2%-68.3%HK$11.2bHK$86.288.716.2%5.2%Household
1797
HK$20.52-4.1%-22.0%HK$21.6bHK$29.4854.524.7%n/aConsumer Retailing
6656
HK$317.8011.8%n/aHK$79.1bHK$621.2123.332.7%0.8%Capital Goods
9658
HK$10.47-4.8%-33.5%HK$6.8bHK$14.4530.430.5%n/aConsumer Services
2506
HK$66.200.5%-36.1%HK$8.0bHK$103.437.554.0%n/aHealthcare
2268
HK$55.408.5%-3.5%HK$70.2bHK$82.8440.825.5%n/aPharmaceuticals & Biotech
2698
HK$35.181.8%n/aHK$21.8bHK$39.7522.915.4%2.0%Household
1768
HK$371.80-6.2%n/aHK$81.0bHK$507.9329.925.5%n/aConsumer Retailing
1357
HK$4.7310.5%-58.3%HK$21.5bHK$8.9725.331.3%2.1%Media
2420
HK$3.79-3.8%7.4%HK$1.9bHK$6.786.122.7%6.1%Retail
Page 1 of 1